The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Astellas Pharma; Bristol-Myers Squibb; Ipsen; MSD Oncology; Novartis; Pfizer; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Roche
Research Funding - Bristol-Myers Squibb (Inst); Ipsen (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD Oncology; Pfizer
Overall survival (OS) and efficacy results of second-line treatment in patients (pts) with metastatic clear cell renal cell carcinoma (mRCC) treated in the randomized phase II BIONIKK trial.
 
Yann-Alexandre Vano
No Relationships to Disclose
 
Letuan Phan
No Relationships to Disclose
 
Audrey Simonaggio
No Relationships to Disclose
 
Mostefa Bennamoun
Honoraria - Astellas Oncology; AstraZeneca; Ipsen; Janssen
 
Diane Pannier
No Relationships to Disclose
 
Christine Chevreau
Consulting or Advisory Role - Bristol-Myers Squibb; ESAÏ; GlaxoSmithKline; Ipsen; Pfizer
Travel, Accommodations, Expenses - IPSEN
 
Delphine Borchiellini
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Ipsen; Janssen-Cilag; Merck; MSD Oncology; Pfizer; Sanofi
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Infinity Pharmaceuticals (Inst); Janssen (Inst); MSD (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Janssen; Pfizer; Roche
 
Denis Maillet
Honoraria - AAA HealthCare; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Ipsen; Janssen; Merck; MSD; Novartis; Pfizer
Travel, Accommodations, Expenses - Ipsen; Janssen; Pfizer
 
Marine Gross-Goupil
Consulting or Advisory Role - Amgen; amgen; Astellas Medivation; AstraZeneca; Bayer/Onyx; Bristol-Myers Squibb; ipsen; Janssen-Cilag; MSD Oncology; Pfizer; Roche; Sanofi
Research Funding - AstraZeneca (Inst); AstraZeneca (Inst); BMS (Inst); ipsen (Inst); Janssen-Cilag (Inst); Merck (Inst); MSD Oncology (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; AstraZeneca; ipsen; ipsen; ipsen; Janssen-Cilag; pfizer; Roche
Other Relationship - Janssen
 
Brigitte Laguerre
Honoraria - Astellas Pharma; AstraZeneca; Ipsen; Ipsen; Ipsen; Janssen-Cilag; MSD Oncology
Travel, Accommodations, Expenses - Astellas Pharma; Janssen; Janssen Oncology; Novartis; Pfizer; Pfizer; pfizer
 
Christophe Tournigand
Honoraria - Bayer; Bristol-Myers Squibb; MSD; Roche; Sanofi
Consulting or Advisory Role - Bayer
Research Funding - Roche
Travel, Accommodations, Expenses - Bayer; MSD; Roche
 
Philippe Barthelemy
Honoraria - Astellas Pharma; BMS; IPSEN; Janssen-Cilag; Merck KGaA; MSD; Novartis; Pfizer; Seagen
Consulting or Advisory Role - Amgen; AstraZeneca; BMS; Eisai; ipsen; Janssen-Cilag; Merck KGaA; MSD Oncology; Pfizer
Travel, Accommodations, Expenses - Astellas Pharma; BMS; IPSEN; Janssen-Cilag; MSD; Pfizer
 
Elodie Coquan
Honoraria - Bristol-Myers Squibb; Ipsen; MSD
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen
Travel, Accommodations, Expenses - Astellas Oncology; Bristol-Myers Squibb; Ipsen; MSD
 
Gwenaelle Gravis
Consulting or Advisory Role - AstraZeneca (Inst); Bayer (Inst); Bayer (Inst); BMS (Inst); IPSEN (Inst); Janssen (Inst); Merck/Pfizer (Inst); MSD Oncology (Inst); Pfizer (Inst); Sanofi/Aventis (Inst)
Speakers' Bureau - Amgen (Inst); Astellas Pharma (Inst); BMS (Inst); Ipsen (Inst); Janssen Oncology (Inst); MSD Oncology (Inst); Sanofi/Aventis (Inst)
Research Funding - BMS (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Ipsen; Janssen Oncology; Pfizer; Sanofi
 
Cheng-Ming Sun
No Relationships to Disclose
 
Maxime Meylan
No Relationships to Disclose
 
Wolf-Hervé Fridman
No Relationships to Disclose
 
Catherine Sautès-Fridman
No Relationships to Disclose
 
Réza Elaidi
No Relationships to Disclose
 
Stephane Oudard
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; Eisai; IPSEN; Janssen; Merck; MSD; Novartis; Pfizer; Roche/Genentech; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; IPSEN; Janssen; Merck; MSD Oncology; MSD Oncology; Novartis; Pfizer; Roche; Roche; Sanofi
Research Funding - Ipsen; Sanofi
Travel, Accommodations, Expenses - Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; Merck; MSD Oncology; Novartis; Pfizer; Roche